According to research that was recently published at ScienceDaily.com, men who are testosterone deficient can be administered testosterone replacement therapy without concern that it will increase their risk of prostate cancer. The research cited by the article was performed primarily in Sweden and involved over 250,000 medical records of mostly caucasian men. Researchers from NYU Langone Medical Center presented their findings last month at the annual meeting of the American Urological Association in San Diego, CA.
"Based on our findings, physicians should still be watching for prostate cancer risk factors -- such as being over the age of 40, having African-American ancestry, or having a family history of the disease -- in men taking testosterone therapy, but should not hesitate to prescribe it to appropriate patients for fear of increasing prostate cancer risk," says lead study investigator and NYU Langone urologist Stacy Loeb, MD, MSc
Read more about this topic by visiting the source article at: https://www.sciencedaily.com/releases/2016/05/160507143326.htm